Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Tischkowitz

Showing results (161-170 of 258) with videos related to

Pageof 26
Sort By:
European Urology|September 10, 2019
Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort StudyTommy Nyberg, Debra Frost, Daniel Barrowdale, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2021
Quantifying evidence toward pathogenicity for rare phenotypes: The case of succinate dehydrogenase genes, SDHB and SDHDAlice Garrett, Chey Loveday, Laura King, et al.
Breast Cancer Research : BCR|May 21, 2025
Distribution of age at natural menopause, age at menarche, menstrual cycle length, height and BMI in BRCA1 and BRCA2 pathogenic variant carriers and non-carriers: results from EMBRACENasim Mavaddat, Debra Frost, Emily Zhao, et al.
Cancer Medicine|June 2, 2023
Development of cancer surveillance guidelines in ataxia telangiectasia: A Delphi-based consensus survey of international expertsRenata Neves, Blanca De Dios Perez, Rafal Panek, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 29, 2019
The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndromeEmma J Crosbie, Neil A J Ryan, Mark J Arends, et al.
European Urology|June 14, 2020
Prostate Cancer Risk by BRCA2 Genomic RegionsTommy Nyberg, Debra Frost, Daniel Barrowdale, et al.
Journal of the National Cancer Institute|May 1, 2013
Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACENasim Mavaddat, Susan Peock, Debra Frost, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 23, 2018
Risks of breast or ovarian cancer in BRCA1 or BRCA2 predictive test negatives: findings from the EMBRACE studyFabio Girardi, Daniel R Barnes, Daniel Barrowdale, et al.
Genome Medicine|December 4, 2021
A functionally impaired missense variant identified in French Canadian families implicates FANCI as a candidate ovarian cancer-predisposing geneCaitlin T Fierheller, Laure Guitton-Sert, Wejdan M Alenezi, et al.
Nature Reviews. Clinical Oncology|July 1, 2020
Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statementNora Pashayan, Antonis C Antoniou, Urska Ivanus, et al.
Pageof 26

Showing results (161-170 of 258) with videos related to

Sort By:
Pageof 26
European Urology|September 10, 2019
Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort StudyTommy Nyberg, Debra Frost, Daniel Barrowdale, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2021
Quantifying evidence toward pathogenicity for rare phenotypes: The case of succinate dehydrogenase genes, SDHB and SDHDAlice Garrett, Chey Loveday, Laura King, et al.
Breast Cancer Research : BCR|May 21, 2025
Distribution of age at natural menopause, age at menarche, menstrual cycle length, height and BMI in BRCA1 and BRCA2 pathogenic variant carriers and non-carriers: results from EMBRACENasim Mavaddat, Debra Frost, Emily Zhao, et al.
Cancer Medicine|June 2, 2023
Development of cancer surveillance guidelines in ataxia telangiectasia: A Delphi-based consensus survey of international expertsRenata Neves, Blanca De Dios Perez, Rafal Panek, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 29, 2019
The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndromeEmma J Crosbie, Neil A J Ryan, Mark J Arends, et al.
European Urology|June 14, 2020
Prostate Cancer Risk by BRCA2 Genomic RegionsTommy Nyberg, Debra Frost, Daniel Barrowdale, et al.
Journal of the National Cancer Institute|May 1, 2013
Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACENasim Mavaddat, Susan Peock, Debra Frost, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 23, 2018
Risks of breast or ovarian cancer in BRCA1 or BRCA2 predictive test negatives: findings from the EMBRACE studyFabio Girardi, Daniel R Barnes, Daniel Barrowdale, et al.
Genome Medicine|December 4, 2021
A functionally impaired missense variant identified in French Canadian families implicates FANCI as a candidate ovarian cancer-predisposing geneCaitlin T Fierheller, Laure Guitton-Sert, Wejdan M Alenezi, et al.
Nature Reviews. Clinical Oncology|July 1, 2020
Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statementNora Pashayan, Antonis C Antoniou, Urska Ivanus, et al.
Pageof 26